Sunshine Lake Pharma Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases,...
Guangdong HEC Pharma wins China NMPA approval for insulin degludec injection
Guangdong HEC Pharma controlling shareholder Zhang lifts stake to 51.42% after buying 1,451,400 H shares for HK$56 million
Guangdong HEC Pharma files HKEX next-day return disclosing share repurchase at HKD 33.82
Hong Kong Niche Stocks Diverge on Earnings Surprises as Commodity, Tech ETFs Track Volatility
Corporate Buybacks and Macro Hedging: Industry Leaders Signal Valuation Floors Amid Uncertainty
The Barbell Reality of Hong Kong Equities: Global Aggregators vs. Local Survivors